Also, Immunohistochemistry (IHC) of the tumor sections for expression of P-gp, HIF-1α, EGFR, HXK2, CD-31, and Stem Cell Factor (SCF) was used to assess the MDR character of the tumors after treatment. Here, EGFR is linked to neoplasm.